CDKN2A and acute lymphoblastic leukemia: In addition, our EMSA experiments with Molt-4 nuclear extracts provide evidence that the RUNX1 heptamer site at a recurrent, recombinase mediated, CDKN2A/B breakpoint described for ETV6-RUNX1 ALL is functionally relevant14.